Center for Medication Development for Substance Use Disorders and Overdose

Our mission is to discover, develop and commercialize novel medications for the prevention and treatment of substance use disorders, overdose and co-morbidities through the development of vaccines, antibody-based strategies and small molecules.


Main Challenge

Millions of individuals live with substance use disorders (SUDs) or are at risk of fatal overdoses. We need innovative strategies to prevent and treat SUDs to improve and save lives.

Our Approach

  • We use translational strategies to develop and test new medications for substance use disorders in preclinical labs and translate these into treatments for humans.
  • We draw upon a continuum of expertise from molecular to cellular biology, vaccine development, advanced drug delivery strategies and animal behavioral approaches to define and validate the potential impact on habitual drug use.
  • We pull together scientists, clinicians, advocates, clients, civic leaders and other shareholders to combat addiction and serve the health needs of the community.

Contact

Marco Pravetoni, PhD
Director, Center for Medication Development for Substance Use Disorders and Overdose
mprave@uw.edu

Department Faculty

Marco Pravetoni, PhD